3 Sources
[1]
Human receives AI-designed virus for the first time
Not to kill the human, of course - to kill the antibiotic-resistant bacteria causing their infection Researchers have administered AI-designed, bacteria-targeting viruses to a person in what they claim is a first, but don't press them for results: They're not ready to say how it went quite
[2]
AI-designed virus infects person for the first time
In a first of a kind trial, a biomedical startup has injected an AI-designed virus into a patient to combat a bacteria infection. Credit: Radical Numerics Would you let an AI-designed virus be injected in your body? Well, at least one individual just did, according to the company behind it. AI
[3]
AI is no longer just coding or generating images. It has now designed a virus that was used on a human being. Did the patient survive?
A California startup has used artificial intelligence to design a virus that was administered to a human patient for the first time. The experimental treatment uses bacteriophages to target antibiotic-resistant bacteria, potentially opening a new way to fight infections that conventional medicines
Share
Copy Link
San Francisco-based Radical Numerics administered AI-designed bacteriophages to a human patient for the first time under compassionate use. The experimental treatment targeted antibiotic-resistant bacteria, marking a shift from laboratory testing to clinical application, though results remain undisclosed.
Radical Numerics, a San Francisco-based AI lab developing bioscience models, announced this week that it has administered an AI-designed phage cocktail to a human patient under a compassionate-use arrangement
1
. The experimental treatment for bacterial infection represents the first time AI-designed bacteriophages have been used clinically on a person, shifting the technology beyond laboratory validation to actual patient care2
.
Source: Mashable
The company's AI model Omnii-1 was used to design viable bacteriophages, viruses that specifically infect bacteria rather than human cells
1
. Radical Numerics modified parts of an existing virus's genetic material, particularly sections that help it recognize and attach to bacteria3
. The AI-designed phage cocktail was tested against bacteria isolated from the patient's antibiotic-resistant infection before administration. Laboratory tests showed the cocktail eliminated the patient's antibiotic-resistant isolate in vitro1
.Phage therapy isn't novel itself, but using AI to design these bacteria-targeting viruses accelerates the process significantly. Bacteriophages offer advantages over antibiotics, most notably their ability to target specific bacterial strains while sparing beneficial gut bacteria that broad-spectrum antibiotics can affect
1
. Finding the right virus for a specific infection traditionally requires searching through collections of naturally occurring viruses to identify one that can target the bacteria causing a patient's illness3
. Antibiotic-resistant bacteria increasingly render conventional medicines ineffective, making alternatives pressing as drug-resistant infections already cause substantial mortality worldwide1
.The research tested Omnii-1's ability to predict which phages could infect Pseudomonas aeruginosa, a bacterium that can develop antibiotic resistance and cause infections in patients with burns and other wounds, as well as persistent lung infections in cystic fibrosis patients
1
. The AI model performed competitively against specialized models at predicting phage-host interactions, though there's nothing to suggest the patient was suffering from a Pseudomonas aeruginosa infection specifically1
.Radical Numerics hasn't disclosed the patient's diagnosis, treatment details, or whether the infection was successfully cleared
3
. The company cited patient confidentiality and the need to protect their privacy as reasons for withholding information1
2
. CEO Eric Nguyen said the team plans to share more details once they receive consent from the patient2
. The announcement wasn't peer-reviewed or published in a scientific journal; instead, the company posted the paper on its website2
. Observations from a single patient don't establish whether the approach is safe or effective for wider clinical application1
.Related Stories
AI has already shown promise in speeding up phage engineering. Researchers from Stanford University and the Arc Institute created AI-designed phages using Evo 2 that targeted E. coli bacteria last year
1
. Of nearly 300 AI-designed viral genomes synthesized and tested, 16 produced functional viruses3
. The phages included several variants that outperformed their biological predecessor in laboratory tests, though those experiments took place in laboratories with bacteria, not human patients1
3
.Radical Numerics hopes its work will lead to a process for designing and building phages targeted to individual bacterial infections
1
. Harvard microbiologist Michael Baym told The New York Times his reaction was cautiously optimistic: "If it works, that's incredible," though he added, "My impulse is to be skeptical"3
. The first human administration marks an important milestone in translating AI-designed biology from computational predictions and laboratory validation to clinical administration1
. While phage therapy can last anywhere from a couple of days to a few weeks, doctors also have to monitor patients for months afterward to ensure the infection was actually cured and won't return2
.Summarized by
Navi
[1]
27 Sept 2025•Science and Research

05 Jun 2026•Health

15 Aug 2025•Science and Research
